Zhejiang Jingxin Pharmaceutical Co Ltd (002020) - Total Assets
Based on the latest financial reports, Zhejiang Jingxin Pharmaceutical Co Ltd (002020) holds total assets worth CN¥7.98 Billion CNY (≈ $1.17 Billion USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See net assets of Zhejiang Jingxin Pharmaceutical Co Ltd for net asset value and shareholders' equity analysis.
Zhejiang Jingxin Pharmaceutical Co Ltd - Total Assets Trend (2001–2024)
This chart illustrates how Zhejiang Jingxin Pharmaceutical Co Ltd's total assets have evolved over time, based on quarterly financial data.
Zhejiang Jingxin Pharmaceutical Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Zhejiang Jingxin Pharmaceutical Co Ltd's total assets of CN¥7.98 Billion consist of 34.3% current assets and 65.7% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 3.7% |
| Accounts Receivable | CN¥895.60 Million | 10.6% |
| Inventory | CN¥792.72 Million | 9.4% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥382.26 Million | 4.5% |
| Goodwill | CN¥348.48 Million | 4.1% |
Asset Composition Trend (2001–2024)
This chart illustrates how Zhejiang Jingxin Pharmaceutical Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of Zhejiang Jingxin Pharmaceutical Co Ltd.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Zhejiang Jingxin Pharmaceutical Co Ltd's current assets represent 34.3% of total assets in 2024, a decrease from 76.2% in 2001.
- Cash Position: Cash and equivalents constituted 3.7% of total assets in 2024, up from 2.8% in 2001.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 8.0% of total assets, an increase from 5.0% in 2001.
- Asset Diversification: The largest asset category is accounts receivable at 10.6% of total assets.
Zhejiang Jingxin Pharmaceutical Co Ltd Competitors by Total Assets
Key competitors of Zhejiang Jingxin Pharmaceutical Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Kangmei Pharmaceutical Co Ltd
SHG:600518
|
China | CN¥13.68 Billion |
|
Beijing New Oriental Star Petrochemical Engineering Co Ltd
SHE:002755
|
China | CN¥4.44 Billion |
|
Zhejiang Jiuzhou Pharm Co Ltd
SHG:603456
|
China | CN¥10.96 Billion |
|
Beijing Winsunny Pharmaceutical CO.LTD
SHG:601089
|
China | CN¥4.69 Billion |
|
KPC Pharmaceuticals Inc
SHG:600422
|
China | CN¥12.01 Billion |
|
Cronos Group Inc
TO:CRON
|
Canada | CA$1.18 Billion |
|
Cheng Du Sheng Nuo Biotec Co. Ltd. A
SHG:688117
|
China | CN¥1.91 Billion |
|
Jiangsu Jibeier Pharmaceutical Co Ltd
SHG:688566
|
China | CN¥2.64 Billion |
Zhejiang Jingxin Pharmaceutical Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.62 | 1.23 | 2.02 |
| Quick Ratio | 1.22 | 0.91 | 1.70 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥1.20 Billion | CN¥547.42 Million | CN¥1.58 Billion |
Zhejiang Jingxin Pharmaceutical Co Ltd - Advanced Valuation Insights
This section examines the relationship between Zhejiang Jingxin Pharmaceutical Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.50 |
| Latest Market Cap to Assets Ratio | 0.22 |
| Asset Growth Rate (YoY) | 6.2% |
| Total Assets | CN¥8.48 Billion |
| Market Capitalization | $1.90 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Zhejiang Jingxin Pharmaceutical Co Ltd's assets below their book value (0.22x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Zhejiang Jingxin Pharmaceutical Co Ltd's assets grew by 6.2% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Zhejiang Jingxin Pharmaceutical Co Ltd (2001–2024)
The table below shows the annual total assets of Zhejiang Jingxin Pharmaceutical Co Ltd from 2001 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥8.48 Billion ≈ $1.24 Billion |
+6.17% |
| 2023-12-31 | CN¥7.99 Billion ≈ $1.17 Billion |
+8.48% |
| 2022-12-31 | CN¥7.36 Billion ≈ $1.08 Billion |
+14.76% |
| 2021-12-31 | CN¥6.42 Billion ≈ $938.77 Million |
+13.22% |
| 2020-12-31 | CN¥5.67 Billion ≈ $829.15 Million |
+0.73% |
| 2019-12-31 | CN¥5.63 Billion ≈ $823.13 Million |
+12.69% |
| 2018-12-31 | CN¥4.99 Billion ≈ $730.45 Million |
+1.79% |
| 2017-12-31 | CN¥4.90 Billion ≈ $717.61 Million |
+49.03% |
| 2016-12-31 | CN¥3.29 Billion ≈ $481.52 Million |
+11.93% |
| 2015-12-31 | CN¥2.94 Billion ≈ $430.20 Million |
+42.39% |
| 2014-12-31 | CN¥2.06 Billion ≈ $302.12 Million |
+55.87% |
| 2013-12-31 | CN¥1.32 Billion ≈ $193.84 Million |
+1.82% |
| 2012-12-31 | CN¥1.30 Billion ≈ $190.37 Million |
+9.09% |
| 2011-12-31 | CN¥1.19 Billion ≈ $174.51 Million |
+25.65% |
| 2010-12-31 | CN¥949.15 Million ≈ $138.89 Million |
+3.48% |
| 2009-12-31 | CN¥917.22 Million ≈ $134.22 Million |
-3.76% |
| 2008-12-31 | CN¥953.08 Million ≈ $139.47 Million |
-6.17% |
| 2007-12-31 | CN¥1.02 Billion ≈ $148.64 Million |
+31.43% |
| 2006-12-31 | CN¥772.85 Million ≈ $113.09 Million |
+35.85% |
| 2005-12-31 | CN¥568.91 Million ≈ $83.25 Million |
+22.31% |
| 2004-12-31 | CN¥465.14 Million ≈ $68.06 Million |
+79.72% |
| 2003-12-31 | CN¥258.80 Million ≈ $37.87 Million |
+41.91% |
| 2002-12-31 | CN¥182.37 Million ≈ $26.69 Million |
+19.59% |
| 2001-12-31 | CN¥152.50 Million ≈ $22.32 Million |
-- |
About Zhejiang Jingxin Pharmaceutical Co Ltd
Zhejiang Jingxin Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products and medical devices in China and internationally. The company offers antihypertensive, antibiotics, quinolones, gastrointestinal promotion, antidiabetic, antiepileptic, antihistamine, H+ pump depressant, antihyper cholesterolemia, histamine H2 receptor blockader, antihyper cholesterolemi… Read more